uniQure (QURE) Income from Continuing Operations (2016 - 2026)
uniQure (QURE) posted Income from Continuing Operations of -$81.1 million for Q2 2026, down 51.41% on a QoQ basis from -$53.5 million in Q1 2026, and down 114.9% year-over-year from $543.9 million in Q2 2025.
Powered by 
Analysis
uniQure (QURE) Income from Continuing Operations (2016 - 2026) Analysis & Trends
uniQure has reported Income from Continuing Operations for 11 years, with the latest figure at -$81.1 million in Q2 2026.
- On a quarterly basis, Income from Continuing Operations fell 114.9% year-over-year to -$81.1 million in Q2 2026; TTM through Jun 2026 was -$196.7 million, a 45.16% decrease from a year earlier, with the FY2025 full-year figure at -$143.5 million, up 18.47% from the prior year.
- Income from Continuing Operations was -$81.1 million for Q2 2026 at uniQure, down from -$53.5 million in the prior quarter.
- The five-year high for Income from Continuing Operations was $38.4 million in Q4 2022, with the low at -$89.6 million in Q3 2023.
- Average Income from Continuing Operations over 5 years is -$43.2 million, with a median of -$47.3 million recorded in 2022.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations plunged 223.65% in 2024, then surged 290.89% in 2025.
- Over 5 years, Income from Continuing Operations stood at $38.4 million in 2022, then sank by 79.68% to $7.8 million in 2023, then slumped by 223.65% to -$9.7 million in 2024, then soared by 290.89% to $18.4 million in 2025, then sank by 539.89% to -$81.1 million in 2026.
- The last three Income from Continuing Operations figures came in at -$81.1 million (Q2 2026), -$53.5 million (Q1 2026), and $18.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 1.10 Bn |
| 10 | uniQure | 2.96 Bn | 2.96 Bn | 5.49 Mn | -81.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -81.06 Mn |
| Mar 31, 2026 | -53.54 Mn |
| Dec 31, 2025 | 18.43 Mn |
| Sep 30, 2025 | -80.53 Mn |
| Jun 30, 2025 | -37.72 Mn |
| Mar 31, 2025 | -43.64 Mn |
| Dec 31, 2024 | -9.65 Mn |
| Sep 30, 2024 | -44.50 Mn |
| Jun 30, 2024 | -56.30 Mn |
| Mar 31, 2024 | -65.62 Mn |
| Dec 31, 2023 | 7.81 Mn |
| Sep 30, 2023 | -89.57 Mn |
| Jun 30, 2023 | -68.47 Mn |
| Mar 31, 2023 | -77.23 Mn |
| Dec 31, 2022 | 38.43 Mn |
| Sep 30, 2022 | -47.86 Mn |
| Jun 30, 2022 | -39.06 Mn |
| Mar 31, 2022 | -46.68 Mn |
| Dec 31, 2021 | -71.78 Mn |
| Sep 30, 2021 | -36.53 Mn |
API Access
uniQure Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=QURE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "QURE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=QURE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();